"antilymphangiogenic" meaning in All languages combined

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "anti",
        "3": "lymphangiogenic"
      },
      "expansion": "anti- + lymphangiogenic",
      "name": "prefix"
    }
  ],
  "etymology_text": "From anti- + lymphangiogenic.",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "antilymphangiogenic (not comparable)",
      "name": "en-adj"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "adj",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms prefixed with anti-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with 1 entry",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with entries",
          "parents": [],
          "source": "w"
        }
      ],
      "examples": [
        {
          "ref": "2015 July 16, “ADAM17 Promotes Motility, Invasion, and Sprouting of Lymphatic Endothelial Cells”, in PLOS ONE, →DOI:",
          "text": "In additional assays, we confirmed the increased expression of BIG-H3, as well as TGFβ2 in ADAM17-silenced LEC. The antilymphangiogenic effects of ADAM17 silencing in lymphatic endothelial cells suggest further relevance of ADAM17 as a potential target in cancer therapy.",
          "type": "quote"
        }
      ],
      "glosses": [
        "That counters lymphangiogenesis"
      ],
      "id": "en-antilymphangiogenic-en-adj-g-GqUUsg",
      "links": [
        [
          "lymphangiogenesis",
          "lymphangiogenesis"
        ]
      ],
      "tags": [
        "not-comparable"
      ]
    }
  ],
  "word": "antilymphangiogenic"
}

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "anti",
        "3": "lymphangiogenic"
      },
      "expansion": "anti- + lymphangiogenic",
      "name": "prefix"
    }
  ],
  "etymology_text": "From anti- + lymphangiogenic.",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "antilymphangiogenic (not comparable)",
      "name": "en-adj"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "adj",
  "senses": [
    {
      "categories": [
        "English adjectives",
        "English entries with incorrect language header",
        "English lemmas",
        "English terms prefixed with anti-",
        "English terms with quotations",
        "English uncomparable adjectives",
        "Pages with 1 entry",
        "Pages with entries"
      ],
      "examples": [
        {
          "ref": "2015 July 16, “ADAM17 Promotes Motility, Invasion, and Sprouting of Lymphatic Endothelial Cells”, in PLOS ONE, →DOI:",
          "text": "In additional assays, we confirmed the increased expression of BIG-H3, as well as TGFβ2 in ADAM17-silenced LEC. The antilymphangiogenic effects of ADAM17 silencing in lymphatic endothelial cells suggest further relevance of ADAM17 as a potential target in cancer therapy.",
          "type": "quote"
        }
      ],
      "glosses": [
        "That counters lymphangiogenesis"
      ],
      "links": [
        [
          "lymphangiogenesis",
          "lymphangiogenesis"
        ]
      ],
      "tags": [
        "not-comparable"
      ]
    }
  ],
  "word": "antilymphangiogenic"
}